The SINUSAVE® product set consists of three drug free formulations currently generating revenue at an annual run rate in excess of $100,000; gross margins exceed 85%. Gross to net > 55%.
SINUSAVE® presents an opportunity to expand our base of >750 customers in all 50 United States and Canada to the next level. Revenue goal: $5.8MM by 12/31/23.
Testimonials on our web site and our Amazon store report attention-grabbing results. We urge you to read their words; nonetheless this is anecdotal commentary. Our plan is to confirm these benefits through formal testing.
SINUSAVE® has become a well-established brand in the nasal congestion relief, wellness, health and natural categories over the past 3 years. The all-natural, drug-free characteristics of the product means it can be used daily across the population to help relieve general discomfort for sufferers of sinusitis, chronic and seasonal allergies, the common cold, flu like symptoms, pollution and mold spores while keeping nasal passages clean and moistened, contributing to overall wellness. Sinusave® is ~ 99.99% bactericidal under USP 51 and certified as a bacteriostatic under USP 61.
Approximately 37 million people in the USA suffer from Sinusitis. An additional 20%, or 65 million suffer from allergies to various pollen. Due to its unique patented formulation, there are no nasal wash products like Sinusave® available to sufferers of the acute nasal congestion common in our world today. There has been very little innovation in this category using all- natural products, without saline added. We believe Sinusave® fills a significant need. Sinusave® is completely safe. It contains no decongestant drugs, no drugs, saline or medicinal compounds.
In March 2017, Sinusave Nasal Health, LLC, a Nevada LLC, was formed as a consumer products company focused on commercial development: marketing, licensing and distribution of its four formulations for a variety of chronic conditions and ailments. In March of 2019 the company reorganized into a C corporation in the State of Nevada. Plans are underway to move all operations to Las Vegas by the end of 2020.
SINUSAVE® was created by an oral and maxillofacial surgeon whose patients dealt with severe nasal blockage after nose and sinus surgery. The initial effort to bring SINUSAVE® to the retail consumer began in 2003. At that time the company had minimal financial resources and virtually no experience in marketing a consumer product. The predecessor company ceased operations in 2009 and all patents and trademarks of the company were assigned to Paul Lobel, an investor, in 2013. The patents and trademarks were later assigned to the company in 2017.
Nevada Secretary of State
Entity Name: ACTUAL NATURAL HEALTH & WELLNESS PRODUCTS, INC.
Entity Number: E0149852019-4
Entity Type: Domestic Corporation (78)
Entity Status: Active
Formation Date: 03/25/2019
NV Business ID: NV20191252674
Termination Date: Perpetual
Annual Report Due Date: 4/30/2021
URL & DOMAIN
https://www.whois.com/whois/sinusave.com
Registered Trademarks
Sinusave®
It’s Like Flossing for Your Nose®
Air Traveler®
It’s Just for Everyone®
Trademark applications
Breathe Easier™
The company is engaged in research and development to expand its all-natural product offerings. To that end, the company has filed two additional patent applications with priority date of May 4, 2018. Those filings provide for added moisturizers and CBD oil. USPTO has commented favorably. Our patent attorney estimates grants by end 2021. Company's current patent # 7.029,705 expires September 15, 2023.
Market and Unmet Health need
Total nasal spray category revenue through September 2019 was $1.2Bn 1. Sinusitis affects about 1 in 7 adults in the United States. The direct cost of managing acute and chronic sinusitis exceeds $11 billion per year, with additional expense from lost productivity, reduced job effectiveness, and impaired quality of life. More than 1 in 5 antibiotics prescribed in adults are for sinusitis, making it the fifth-most common diagnosis responsible for antibiotic therapy. Despite the high prevalence and economic impact of sinusitis, considerable practice variations exist across and within the multiple disciplines involved in managing the condition. The nasal hygiene category is growing significantly as people become more aware that keeping their nose clean is as important as the daily brushing and flossing of their teeth. In addition, increased understanding of the benefits of using nasal wash not only for relief from existing conditions, but also as a deterrent to future disorders is further driving sales. Please read Testimonials on our web site and reviews on Amazon.
Some important facts demonstrating the potential size of the market include:
· According to the American Rhinologic Society chronic sinusitis affects approximately 15% of the U.S. population or > 46 million people suffer at least one episode of acute sinusitis a year.
· Acute bacterial rhinosinusitis is very frequently associated with viral upper respiratory tract infection, although allergy, trauma, neoplasms, granulomatous and inflammatory diseases, midline destructive disease, environmental factors, dental infection, and anatomic variation, which may impair normal Mucociliary Clearance and may also predispose to bacterial infection.
· The prevalence of sinusitis has soared in the last decade, widely accepted as being due to increased pollution, urban sprawl, and increased resistance to antibiotics.
· According to Salu.net, the U.S. allergy market is believed to be an $11 billion marketplace.
· The leading decongestant drug remedies each reach sales exceeding $600 million annually.
•Founder / Partner, Identification Solutions, LLC (US) a pioneering RFID & Smart card development company
•Partner, Director, Sales and Marketing, TDA Operations, UK
•President, Protect @ Defend – Automotive theft systems direct to retail
•Regional Sales Manager, Racal Electronics Group
•National Sales Manager, Penril Data Communications
•Communications site manager, Project Gemini/Apollo – Atlantic Missile Range
•Vietnam Era - US Air Force veteran – Strategic Air Command
Lou Lobel, Sr. VP Sales & Marketing
•Principal developer – Social Media platforms
•20 years as professional manager of general and specialized hospitality services. Expert in providing consistent customer service, building and maintaining repeat business and identifying new target markets through market based advertising and public relations programs.
•Founder, Owner, CEO; VipMe® (Club Access) Las Vegas, NV
•Owner and General Manager
•Edward Lewis Action Photography – Atlanta, GA
•All seasons Youth Sports League action photography. Exclusive to Georgia Youth Sports Association.
Bruce E. Artman, M.S., CFS, Chief Scientist
- 31 years in Food & Personal care science product development.
- Managed large staff. Degrees in Food and Nutrition Science (Chemistry minor)
- Food Applications experience in Dairy, Beverage,
- Built Labs & Managed Facilities
- Certified Food Scientist by Institute of Food Technology
- Manufacturing, QC & QA experience
- Pharma-Drug exposure
- R&D Executive with Operations, Quality and Regulatory.
- Passion for targeting Health & Wellness initiatives.
Manufacturing & Warehousing
SINUSAVE® is manufactured by Alternative Laboratories, an FDA regulated and certified facility. Alternative Labs operations are located in Naples, FL and Ft. Myers, FL a combined 100,000 sq. ft. employing a staff of over 100 including chemists, laboratory technicians and support staff for turn-key manufacturing. Kevin Thomas, is the founder & CEO of Alternative Laboratories. He has dedicated his life's work to the global research, development, and manufacturing of natural alternative and homeopathic healing remedies.
Warehousing and fulfillment services are located in Las Vegas, NV.
https://www.sinusave.com